Aswin L. Hoffmann

Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

Loes van Keimpema, Frederik Nevens, Ragna Vanslembrouck et al. · Gastroenterology · 2009 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Comparison of Five Segmentation Tools for 18F-Fluoro-Deoxy-Glucose–Positron Emission Tomography–Based Target Volume Definition in Head and Neck Cancer

Dominic A.X. Schinagl, Wouter V. Vogel, Aswin L. Hoffmann et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 212 citations

Medicine, Nuclear Medicine, Radiology +16

IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI

Emile N.J.T. van Lin, Jurgen J. Fütterer, Stijn W. T. P. J. Heijmink et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 171 citations · Full text

Medicine, Radiation Oncology, Radiology +15

¹⁸F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors

Esther G.C. Troost, Johan Bussink, Aswin L. Hoffmann et al. · Journal of Nuclear Medicine · 2010 · 157 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A novel iterative method for lesion delineation and volumetric quantification with FDG PET

Jorn A. van Dalen, Aswin L. Hoffmann, Volker Dicken et al. · Nuclear Medicine Communications · 2007 · 113 citations

Medicine, Nuclear Medicine, Radiology +15